We found that treatment with Chol-PCX/anti-miR-155 nanoparticles significantly decreased the level of ALT and slightly decreased AST when compared with the untreated AALD fibrosis group (EtOH/CCl4 + PBS-injected) (Figure 9D,E). This evidence concerns the gene GPT and fibrosis.